GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
Mingming Zhang, Guoqing Wei, Linghui Zhou, Jincai Zhou, Siye Chen, Wei Zhang, Dongrui Wang, Xueping Luo, Jiazhen Cui, Simao Huang, Shan Fu, Xinkai Zhou, Yu Tang, Xiaomin Ding, Jiao Kuang, Xiaowen He, Yongxian Hu, He Huang
Topics & Concepts
MedicineMultiple myelomaRefractory (planetary science)Chimeric antigen receptorInternal medicinePhases of clinical researchLenalidomideOncologyGastroenterologyChemotherapyImmunotherapyCancerAstrobiologyPhysicsCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsImmunotherapy and Immune Responses